PUBLISHER: Global Insight Services | PRODUCT CODE: 2171078
PUBLISHER: Global Insight Services | PRODUCT CODE: 2171078
The global brain mapping instruments market is projected to grow from $2.8 billion in 2025 to $5.9 billion by 2035, at a compound annual growth rate (CAGR) of 7.7%. The brain mapping instruments market is supported by continued investment in neuroimaging, neural recording, and technologies for studying brain connectivity. In 2026, the U.S. National Institutes of Health reported that the BRAIN Initiative received a total FY2026 allocation of $429 million, comprising $234 million in base funding and $195 million under the 21st Century Cures Act. The initiative supports research involving advanced neuroimaging technologies, neural recording and modulation tools, and technologies for studying brain structure, function, and connectivity across multiple scales. This continued public investment supports development and adoption of technologies used in brain mapping and neuroscience research.
By type, Electroencephalography (EEG) dominated the brain mapping instruments market in 2025 owing to its widespread use for measuring and analyzing brain electrical activity across clinical and research settings. EEG systems provide real-time neural activity monitoring, making them valuable for epilepsy evaluation, sleep studies, neurological assessments, cognitive research, and brain function analysis. Their non-invasive nature, relatively lower cost, portability, and broad availability supported adoption across hospitals, diagnostic centers, and research institutes. Technological improvements in high-density electrode arrays, wireless systems, signal processing, and software-based analysis have further enhanced EEG capabilities. Growing demand for accessible neurological diagnostics and continuous brain activity monitoring is expected to sustain the segment during the forecast period.
| Market Segmentation | |
|---|---|
| Type | Functional Magnetic Resonance Imaging (fMRI), Electroencephalography (EEG), Magnetoencephalography (MEG), Near-Infrared Spectroscopy (NIRS), Positron Emission Tomography (PET), Computed Tomography (CT), Transcranial Magnetic Stimulation (TMS), Others |
| Product | Brain Mapping Devices, Software Solutions, Accessories, Others |
| Services | Consulting Services, Installation Services, Maintenance Services, Training and Education, Others |
| Technology | Non-Invasive, Invasive, Others |
| Component | Sensors, Amplifiers, Data Acquisition Systems, Others |
| Application | Neuroscience Research, Clinical Diagnostics, Neuropsychology, Surgical Planning, Others |
| End User | Hospitals, Research Institutes, Diagnostic Centers, Academic Institutes, Others |
| Functionality | Real-Time Monitoring, Offline Analysis, Others |
| Equipment | Portable Devices, Fixed Systems, Others |
| Solutions | Cloud-Based Solutions, On-Premise Solutions, Hybrid Solutions, Others |
By technology, non-invasive is expected to be the fastest-growing segment during the forecast period owing to its broad applicability and lower procedural risks compared with invasive brain mapping techniques. Non-invasive technologies such as EEG, fMRI, MEG, NIRS, PET, and TMS enable assessment or modulation of brain activity without requiring surgical access to neural tissue. Their use across neuroscience research, clinical diagnostics, neuropsychology, and surgical planning is expanding as healthcare providers seek safer and more accessible brain assessment methods. Advances in wearable sensors, portable devices, high-resolution imaging, real-time monitoring, and computational analysis are expected to improve usability and accuracy. Increasing neurological research and demand for patient-friendly diagnostic approaches will further support segment growth.
North America dominated the global brain mapping instruments market in 2025, supported by advanced healthcare infrastructure, strong neuroscience research capabilities, and widespread adoption of sophisticated neurological diagnostic technologies. The United States represents a major contributor to regional demand, supported by established hospitals, specialized neurological centers, academic research institutions, and the presence of leading medical technology companies. Increasing use of advanced imaging and brain-monitoring technologies for neurological diagnosis, treatment planning, and research is supporting market development. The region also benefits from continued technological innovation and established clinical expertise in neuroimaging and brain activity assessment.
Asia Pacific is expected to be the fastest-growing region in the brain mapping instruments market during the forecast period, driven by expanding healthcare infrastructure, increasing neurological disease diagnosis, and growing adoption of advanced medical imaging technologies. China, Japan, India, and South Korea are contributing to regional expansion through investments in healthcare facilities, neuroscience research, and diagnostic capabilities. Rising awareness of neurological disorders and increasing access to specialized healthcare services are creating additional demand for brain mapping technologies. The expansion of hospitals and diagnostic centers, together with increasing adoption of EEG, MRI, PET, and other brain mapping technologies, is further supporting regional market development.
Convergence of Multimodal Technologies for Neural Mapping
The brain mapping instruments market is moving toward multimodal systems that combine complementary technologies to capture structural, functional, and electrical characteristics of the brain. Instrument platforms are increasingly designed to integrate neuroimaging, electrophysiological recording, and advanced signal-processing capabilities, enabling researchers and clinicians to obtain more comprehensive information from complex neural activity. Improvements in spatial and temporal resolution, sensor sensitivity, data synchronization, and visualization are enhancing the interpretation of brain signals. Greater compatibility between instruments, software, and analytical platforms is also supporting more efficient workflows across neuroscience research, neurological diagnostics, brain-computer interface development, and clinical investigations.
Broader Neuroscience Research and Neurological Assessment
Demand for brain mapping instruments is being supported by expanding research into brain structure, neural connectivity, cognition, neurological disorders, and brain function. Researchers and healthcare professionals require increasingly detailed measurements to understand complex neural processes and identify abnormalities associated with neurological conditions. Growth in neuroscience laboratories, specialized research centers, and advanced neurological assessment programs is creating additional demand for high-resolution mapping technologies. The increasing use of quantitative brain data in disease research, treatment planning, rehabilitation, and experimental therapies is further encouraging adoption of sophisticated instruments capable of capturing and analyzing multiple dimensions of brain activity.
Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.